Genome-Wide Association Study-Driven Gene-Set Analyses, Genetic, and Functional Follow-Up Suggest GLIS1 as a Susceptibility Gene for Mitral Valve Prolapse.


Journal

Circulation. Genomic and precision medicine
ISSN: 2574-8300
Titre abrégé: Circ Genom Precis Med
Pays: United States
ID NLM: 101714113

Informations de publication

Date de publication:
05 2019
Historique:
entrez: 22 5 2019
pubmed: 22 5 2019
medline: 9 7 2020
Statut: ppublish

Résumé

Background Mitral valve prolapse (MVP) is a common heart valve disease, the most frequent indication for valve repair or replacement. MVP is characterized by excess extracellular matrix secretion and cellular disorganization, which leads to bulky valves that are unable to coapt correctly during ventricular systole resulting in mitral regurgitation, and it is associated with sudden cardiac death. Here we aim to characterize globally the biological mechanisms underlying genetic susceptibility to MVP to better characterize its triggering mechanisms. Methods We applied i-GSEA4GWAS and DEPICT, two pathway enrichment tools to MVP genome-wide association studies. We followed-up the association with MVP in an independent dataset of cases and controls. This research was conducted using the UK Biobank Resource. Immunohistochemistry staining for Glis1 (GLIS family zinc finger 1) was conducted in developing heart of mice. Knockdown of Glis1 using morpholinos was performed in zebrafish animals 72 hours postfertilization. Results We show that genes at risk loci are involved in biological functions relevant to actin filament organization, cytoskeleton biology, and cardiac development. The enrichment for positive regulation of transcription, cell proliferation, and migration motivated the follow-up of GLIS1, a transcription factor from the Krüppel-like zinc finger family. In combination with previously available data, we now report a genome-wide significant association with MVP (odds ratio, 1.20; P=4.36×10

Identifiants

pubmed: 31112420
doi: 10.1161/CIRCGEN.119.002497
pmc: PMC6532425
mid: NIHMS1527114
doi:

Substances chimiques

DNA-Binding Proteins 0
GLIS1 protein, human 0
Glis1 protein, mouse 0
Transcription Factors 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e002497

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL038176
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL141917
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL067434
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL105780
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL127692
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL092577
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128099
Pays : United States
Organisme : NHLBI NIH HHS
ID : K01 HL140187
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128914
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL131546
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL072265
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500001I
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL080124
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL116652
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL126136
Pays : United States

Références

N Engl J Med. 1999 Jul 1;341(1):1-7
pubmed: 10387935
Circulation. 2002 Sep 10;106(11):1355-61
pubmed: 12221052
J Am Coll Cardiol. 2002 Oct 2;40(7):1298-304
pubmed: 12383578
Am J Hum Genet. 2005 Jan;76(1):8-32
pubmed: 15549674
Circulation. 2007 Jan 2;115(1):40-9
pubmed: 17190868
Mol Cell Biol. 2008 Sep;28(18):5687-97
pubmed: 18644866
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W90-5
pubmed: 20435672
Nature. 2011 Jun 08;474(7350):225-9
pubmed: 21654807
PLoS One. 2011;6(7):e21800
pubmed: 21789182
Annu Rev Med. 2012;63:277-92
pubmed: 22248324
Nature. 2012 Apr 11;485(7398):376-80
pubmed: 22495300
Nat Genet. 2012 Apr 29;44(6):670-5
pubmed: 22544366
Cardiovasc Res. 2012 Oct 1;96(1):109-19
pubmed: 22843703
Circulation. 2015 Jan 20;131(3):263-8
pubmed: 25361552
Cell. 2014 Dec 18;159(7):1665-80
pubmed: 25497547
Nat Commun. 2015 Jan 19;6:5890
pubmed: 25597830
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Nature. 2015 Sep 3;525(7567):109-13
pubmed: 26258302
Nat Genet. 2015 Oct;47(10):1206-11
pubmed: 26301497
Nat Rev Cardiol. 2015 Dec;12(12):689-710
pubmed: 26483167
Mayo Clin Proc. 2016 Mar;91(3):336-42
pubmed: 26856780
Front Pharmacol. 2017 Aug 23;8:556
pubmed: 28878674
Mol Cell. 2017 Sep 21;67(6):1037-1048.e6
pubmed: 28890333
Eur Heart J. 2018 Apr 14;39(15):1269-1277
pubmed: 29020406
Stem Cell Investig. 2017 Sep 27;4:80
pubmed: 29057252
Cell Mol Life Sci. 2018 Oct;75(19):3473-3494
pubmed: 29779043
Ann Thorac Surg. 2018 Sep;106(3):716-727
pubmed: 30032907

Auteurs

Mengyao Yu (M)

INSERM, UMR970, Paris Cardiovascular Research Center, France (M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.).
Faculty of Medicine, University Paris Descartes, Sorbonne Paris Cité, France (M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.).

Adrien Georges (A)

INSERM, UMR970, Paris Cardiovascular Research Center, France (M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.).
Faculty of Medicine, University Paris Descartes, Sorbonne Paris Cité, France (M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.).

Nathan R Tucker (NR)

Cardiology Division, Cardiovascular Research Center (N.R.T., P.T.E., D.J.M.), Massachusetts General Hospital, Harvard Medical School, Boston.
Precision Cardiology Laboratory, The Broad Institute, Cambridge, MA (N.R.T., P.T.E.).

Sergiy Kyryachenko (S)

INSERM, UMR970, Paris Cardiovascular Research Center, France (M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.).
Faculty of Medicine, University Paris Descartes, Sorbonne Paris Cité, France (M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.).

Katelyn Toomer (K)

Cardiovascular Developmental Biology Center, Department of Regenerative Medicine and Cell Biology, College of Medicine, Children's Research Institute, Medical University of South Carolina, Charleston (K.T.).

Jean-Jacques Schott (JJ)

Inserm U1087, institut du thorax, University Hospital Nantes, France (J.-J.S., C.D.).
CNRS, UMR 6291, Université de Nantes, France (J.-J.S., C.D.).
Université de Nantes, France (J.-J.S., C.D.).

Francesca N Delling (FN)

Department of Medicine, Division of Cardiology, University of California, San Francisco (F.N.D.).

Leticia Fernandez-Friera (L)

HM Hospitales-Centro Integral de Enfermedades Cardiovasculares HM-CIEC, Madrid, Spain (L.F.-F., J.S.).
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain (L.F.-F., J.S.).

Jorge Solis (J)

HM Hospitales-Centro Integral de Enfermedades Cardiovasculares HM-CIEC, Madrid, Spain (L.F.-F., J.S.).
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain (L.F.-F., J.S.).

Patrick T Ellinor (PT)

Cardiology Division, Cardiovascular Research Center (N.R.T., P.T.E., D.J.M.), Massachusetts General Hospital, Harvard Medical School, Boston.
Precision Cardiology Laboratory, The Broad Institute, Cambridge, MA (N.R.T., P.T.E.).

Robert A Levine (RA)

Cardiac Ultrasound Laboratory, Cardiology Division (R.A.L.), Massachusetts General Hospital, Harvard Medical School, Boston.

Susan A Slaugenhaupt (SA)

Center for Human Genetic Research, Massachusetts General Hospital and Department of Neurology, Harvard Medical School, Boston (S.A.S.).

Albert A Hagège (AA)

INSERM, UMR970, Paris Cardiovascular Research Center, France (M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.).
Faculty of Medicine, University Paris Descartes, Sorbonne Paris Cité, France (M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.).
Department of Cardiology (A.A.H.), Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, France.

Christian Dina (C)

Inserm U1087, institut du thorax, University Hospital Nantes, France (J.-J.S., C.D.).
CNRS, UMR 6291, Université de Nantes, France (J.-J.S., C.D.).
Université de Nantes, France (J.-J.S., C.D.).

Xavier Jeunemaitre (X)

INSERM, UMR970, Paris Cardiovascular Research Center, France (M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.).
Faculty of Medicine, University Paris Descartes, Sorbonne Paris Cité, France (M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.).
Department of Genetics (X.J.), Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, France.

David J Milan (DJ)

Cardiology Division, Cardiovascular Research Center (N.R.T., P.T.E., D.J.M.), Massachusetts General Hospital, Harvard Medical School, Boston.

Nabila Bouatia-Naji (N)

INSERM, UMR970, Paris Cardiovascular Research Center, France (M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.).
Faculty of Medicine, University Paris Descartes, Sorbonne Paris Cité, France (M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.M.Y., A.G., S.K., A.A.H., X.J., N.B.-N.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH